MedWellAI Income Statement (2011-2026) | MWAI

Income Statement Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.89M1.92M2.55M1.43M0.66M0.56M0.37M1.47M1.46M1.06M1.73M1.98M-4.77M0.00M0.14M0.28M0.17M0.10M0.55M0.62M
Cost of Revenue (Quarter)
0.30M1.07M0.81M1.12M0.86M0.77M0.68M0.98M1.10M0.84M1.17M1.20M0.72M
Gross Profit (Quarter)
0.59M0.84M1.74M0.31M-0.20M-0.21M-0.31M-1.01M-0.91M-0.51M-0.19M0.79M-5.49M0.00M0.14M0.28M
Operating items
Research & Development (Quarter)
0.02M250.00
Selling, General & Administrative (Quarter)
5.69M0.21M2.07M0.12M0.82M0.39M0.30M0.34M14.96M8.49M0.19M0.24M0.36M0.34M0.63M1.13M0.46M0.40M0.41M0.36M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
0.21M-0.05M-0.05M-0.46M1.71M1.63M-0.12M-0.98M0.25M0.04M-0.21M0.01M0.41M0.48M
Operating Expenses (Quarter)
5.69M0.21M2.07M0.17M0.92M0.39M0.30M3.19M-5.44M10.12M2.06M1.66M-4.77M0.59M0.46M1.10M1.29M0.42M0.82M0.85M
Operating Income (Quarter)
-5.10M0.63M-0.33M0.14M-1.13M-0.61M-0.61M-1.72M-22.12M-9.06M-0.34M0.32M0.00M-0.59M-0.32M-0.81M-1.12M-0.33M-0.27M-0.23M
EBIT (Quarter)
-5.10M0.63M-0.33M0.14M-1.13M-0.61M-0.61M-1.72M-22.12M-9.06M-0.34M0.32M0.00M-0.59M-0.32M-0.81M-1.12M-0.33M-0.27M-0.23M
Non-operating items
Non Operating Investment Income (Quarter)
0.72M-0.19M-0.02M-0.04M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
-0.76M0.72M-0.18M0.12M-0.18M-0.15M-0.05M-0.02M-0.02M0.07M-0.06M-0.01M-0.01M-0.25M-0.01M
Net income details
EBT (Quarter)
-5.26M1.35M-0.52M-0.07M-1.32M-0.79M-0.76M-1.77M-22.14M-9.08M-0.36M0.30M-0.01M-0.66M-0.33M-0.83M-1.14M-0.58M-0.29M-0.24M
Tax Provisions (Quarter)
-4.71M4.90M
Profit After Tax (Quarter)
-5.26M1.35M-0.52M-0.07M-1.32M-0.79M-0.76M-1.77M-22.14M-9.08M-0.36M0.30M9.10M-1.24M-0.73M-0.83M-1.13M-0.65M-0.29M-0.24M
Income from Non-Controlling Interests (Quarter)
-0.03M-0.06M-0.05M-0.04M-0.00M-98.00-427.00
Income from Continuing Operations (Quarter)
-0.55M1.35M-0.52M-0.07M-1.32M-0.79M-0.76M-1.77M-27.05M-9.08M-0.36M0.30M-0.01M-0.66M-0.33M-0.83M-1.14M-0.58M-0.29M-0.24M
Consolidated Net Income (Quarter)
-0.55M1.35M-0.52M-0.07M-1.32M-0.79M-0.76M-1.77M-27.05M-9.08M-0.36M0.30M-0.01M-0.58M-0.40M0.19M-0.04M-0.07M
Income towards Parent Company (Quarter)
-0.55M1.35M-0.52M-0.07M-1.32M-0.79M-0.76M-1.77M-27.05M-9.08M-0.36M0.30M-0.01M-0.58M-0.40M0.19M-0.04M-0.07M
Preferred Dividend Payments (Quarter)
-0.38M0.13M0.14M0.14M-0.41M0.15M0.63M0.20M0.21M0.21M0.21M0.07M
Net Income towards Common Stockholders (Quarter)
-5.84M1.22M-0.65M-0.21M-1.47M-1.10M-1.40M-2.06M-22.35M-9.29M-0.57M0.23M-2.38M-1.22M-0.67M-0.59M-1.13M-0.65M-0.29M-0.24M
Additional items
EPS (Basic) (Quarter)
-0.040.010.000.00-0.010.00-0.01-0.88-9.95-2.81-0.130.04-0.54-0.24-0.13-0.10-0.19-0.11-0.05-0.01
EPS (Diluted) (Quarter)
-0.040.000.000.00-0.01-0.01-0.01-0.88-9.95-2.81-0.130.01-0.54-0.24-0.13-0.10-0.20-0.11-0.05-0.04
Shares Outstanding (Quarter)
146.04M203.61M205.01M205.15M204.71M224.41M250.08M2.34M2.25M3.31M4.23M5.06M4.41M5.08M5.08M5.95M5.95M5.95M5.95M29.75M
Shares Outstanding (Diluted) (Quarter)
154.41M285.53M205.01M205.15M205.15M205.15M250.08M2.34M2.25M3.31M4.23M18.30M4.41M5.08M5.32M5.95M5.71M6.19M6.28M6.24M
Shares Outstanding (Entity) (Quarter)
146.04M204.96M205.15M205.15M207.25M246.75M250.67M2.78M2.25M3.31M5.06M5.06M5.06M5.16M5.24M6.14M6.19M6.24M6.24M29.75M
EBITDA (Quarter)
-5.10M0.63M-0.33M0.14M-1.13M-0.61M-0.61M-1.72M-22.12M-9.06M-0.34M0.32M0.00M-0.59M-0.32M-0.81M-1.12M-0.33M-0.27M-0.23M
Interest Expenses (Quarter)
0.43M382.0080.0053.0026.000.06M0.11M0.15M0.02M0.02M0.02M0.02M0.03M0.01M0.03M0.13M-0.01M0.03M0.03M0.03M
Tax Rate (Quarter)
89.61%-22.14%